Live WebinarTesting the depth of the river with both feet: the ozone breakthrough in dentistry
01 Dec 2020, 05:00 PM Prague
Prof. Annamaria Genovesi
November 25, 2020 | Events, Interviews, News
WASHINGTON, U.S.: Another court case in the drawn-out patent battle between Align Technology and 3Shape has come to a close. A notice of final determination issued by the U.S. International Trade Commission (ITC) found that there was no Section 337 violation and that, while 3Shape had infringed upon certain Align patent claims, those claims were found to be invalid. Furthermore, of the two Align patents that were found to be valid, the ITC determined that neither had been infringed by 3Shape.
October 26, 2020 | Events, Interviews, News
LEIPZIG, Germany: For the American legal teams of both Align Technology and 3Shape, 19 October was an exceptionally busy day. While Align dropped a patent infringement case against 3Shape in the US District Court for the District of Delaware, it brought forward an almost identical case in the District Court for the Western District of Texas, alleging that 3Shape had infringed upon seven of its patents. The cases are the latest examples of the two dental companies clashing on the intellectual property front, a fight that seems unlikely to abate any time soon.
October 19, 2020 | Events, Interviews, News
COPENHAGEN, Denmark: Whereas it was previously impossible to imagine a dental laboratory adopting a fully digital workflow, digital dentistry has already redefined the previously established dental procedures and empowered dental professionals and clinicians to take the leap and immerse themselves in a digital future. The benefits of dental technology can be clearly seen in the introduction of digital dentures—not only has this facilitated denturists’ and dental clinicians’ work by offering more flexibility and efficiency, but it has also improved the patient experience and enabled patients to become more involved in their own care.
3Shape CAD Points is a getting-started or business expansion package for labs that want to offer a wider range of indications with a minimal up-front investment.